The regulation of uterine relaxation

Seminars in Cell and Developmental Biology

Volumn 18, Issue 3, 2007, Pages 340-347

  Lopez Bernal A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cyclic nucleotides; GPCR; Myometrium; Phosphodiesterases; Tocolytics

Indexed keywords

8 BROMO CYCLIC AMP; 8 BROMO CYCLIC GMP; ACETYLCHOLINE; ADRENOMEDULLIN; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; HISTAMINE; ION CHANNEL; MAGNESIUM SULFATE; NIFEDIPINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OXYTOCIN ANTAGONIST; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PROGESTERONE; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; REGULATOR PROTEIN; RITODRINE; ROLIPRAM; SEROTONIN; TERBUTALINE; THROMBOXANE A2; UNINDEXED DRUG;

CHANNEL GATING; ENZYME ACTIVITY; FETUS OUTCOME; HUMAN; HYPOTENSION; MYOMETRIUM; PREMATURE LABOR; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; TACHYCARDIA; TOCOLYSIS; UNSPECIFIED SIDE EFFECT; UTERUS RELAXATION;

EID: 34547702101     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2007.05.002     Document Type: Review

References (77)

1. Liggins G.C. The role of the hypothalamic-pituitary-adrenal axis in preparing the fetus for birth. Am J Obstet Gynecol 182 (2000) 475
2. Keirse M.J. New perspectives for the effective treatment of preterm labor. Am J Obstet Gynecol 173 (1995) 618
3. Buhimschi I., Yallampalli C., Dong Y.L., and Garfield R.E. Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol 172 (1995) 1577
4. Telfer J.F., Itoh H., Thomson A.J., Norman J.E., Nakao K., Campa J.S., et al. Activity and expression of soluble and particulate guanylate cyclases in myometrium from nonpregnant and pregnant women: down-regulation of soluble guanylate cyclase at term. J Clin Endocrinol Metab 86 (2001) 5934
5. Word R.A., Casey M.L., Kamm K.E., and Stull J.T. Effects of cGMP on [Ca2+]i, myosin light chain phosphorylation, and contraction in human myometrium. Am J Physiol 260 (1991) C861
6. Buxton I.L. Regulation of uterine function: a biochemical conundrum in the regulation of smooth muscle relaxation. Mol Pharmacol 65 (2004) 1051
7. Farina M.G., Billi S., Sordelli M.S., Ribeiro M.L., Di Girolamo G., Lombardi E., et al. Nitric oxide (NO) inhibits prostaglandin E2 9-ketoreductase (9-KPR) activity in human fetal membranes. Prostagland Lipid Mediat 79 (2006) 260
8. Bisits A., Madsen G., Knox M., Gill A., Smith R., Yeo G., et al. The randomized nitric oxide tocolysis trial (RNOTT) for the treatment of preterm labor. Am J Obstet Gynecol 191 (2004) 683
9. Brainard A.M., Miller A.J., Martens J.R., and England S.K. Maxi-K channels localize to caveolae in human myometrium: a role for an actin-channel-caveolin complex in the regulation of myometrial smooth muscle K+ current. Am J Physiol Cell Physiol 289 (2005) C49
10. Anwer K., Oberti C., Perez G.J., Perez-Reyes N., McDougall J.K., Monga M., et al. Calcium-activated K+ channels as modulators of human myometrial contractile activity. Am J Physiol 265 (1993) C976
11. Khan R.N., Smith S.K., Morrison J.J., and Ashford M.L. Ca2+ dependence and pharmacology of large-conductance K+ channels in nonlabor and labor human uterine myocytes. Am J Physiol 273 (1997) C1721
12. Bai X., Bugg G.J., Greenwood S.L., Glazier J.D., Sibley C.P., Baker P.N., et al. Expression of TASK and TREK, two-pore domain K+ channels, in human myometrium. Reproduction 129 (2005) 525
13. Huang S.Y., Tsai M.L., Wu C.J., Hsu J.L., Ho S.H., and Chen S.H. Quantitation of protein phosphorylation in pregnant rat uteri using stable isotope dimethyl labeling coupled with IMAC. Proteomics 6 (2006) 1722
14. Watts V.J., and Neve K.A. Sensitization of adenylate cyclase by Galpha i/o-coupled receptors. Pharmacol Ther 106 (2005) 405
15. Europe-Finner G.N., Phaneuf S., Tolkovsky A.M., Watson S.P., and Lopez Bernal A. Down-regulation of G alpha s in human myometrium in term and preterm labor: a mechanism for parturition. J Clin Endocrinol Metab 79 (1994) 1835
16. Litime M.H., Pointis G., Breuiller M., Cabrol D., and Ferre F. Disappearance of beta-adrenergic response of human myometrial adenylate cyclase at the end of pregnancy. J Clin Endocrinol Metab 69 (1989) 1
17. Lecrivain J.L., Cohen-Tannoudji J., Robin M.T., Coudouel N., Legrand C., and Maltier J.P. Molecular mechanisms of adenylyl cyclase desensitization in pregnant rat myometrium following in vivo administration of the beta-adrenergic agonist, isoproterenol. Biol Reprod 59 (1998) 45
18. Chanrachakul B., Matharoo-Ball B., Turner A., Robinson G., Broughton-Pipkin F., Arulkumaran S., et al. Reduced expression of immunoreactive beta2-adrenergic receptor protein in human myometrium with labor. J Clin Endocrinol Metab 88 (2003) 4997
19. Frambach T., Muller T., Freund S., Engelhardt S., Sutterlin M., Lohse M.J., et al. Self-limitation of intravenous tocolysis with beta2-adrenergic agonists is mediated through receptor G protein uncoupling. J Clin Endocrinol Metab 90 (2005) 2882
20. Bender A.T., and Beavo J.A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58 (2006) 488
21. Kofinas A.D., Rose J.C., and Meis P.J. Changes in cyclic adenosine monophosphate-phosphodiesterase activity in nonpregnant and pregnant human myometrium. Am J Obstet Gynecol 157 (1987) 733
22. Berg G., Andersson R.G., and Ryden G. Effects of different phosphodiesterase-inhibiting drugs on human pregnant myometrium: an in vitro study. Arch Int Pharmacodyn Ther 290 (1987) 288
23. Leroy M.J., Cedrin I., Breuiller M., Giovagrandi Y., and Ferre F. Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term. Biochem Pharmacol 38 (1989) 9
24. Leroy M.J., Pichard A.L., Cabrol D., and Ferre F. Cyclic 3′:5′-nucleotide phosphodiesterase in human myometrium at the end of pregnancy: partial purification and characterization of the different soluble isoenzymes. Gynecol Obstet Invest 20 (1985) 27
25. Leroy M.J., Lugnier C., Merezak J., Tanguy G., Olivier S., Le Bec A., et al. Isolation and characterization of the rolipram-sensitive cyclic AMP-specific phosphodiesterase (type IV PDE) in human term myometrium. Cell Signal 6 (1994) 405
26. Oger S., Mehats C., Dallot E., Ferre F., and Leroy M.J. Interleukin-1beta induces phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin E2- and cyclic adenosine 3′5′-monophosphate-dependent pathway. J Clin Endocrinol Metab 87 (2002) 5524
27. Oger S., Mehats C., Barnette M.S., Ferre F., Cabrol D., and Leroy M.J. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors. Biol Reprod 70 (2004) 458
28. Mehats C., Oger S., and Leroy M.J. Cyclic nucleotide phosphodiesterase-4 inhibitors: a promising therapeutic approach to premature birth?. Eur J Obstet Gynecol Reprod Biol 117 1 (2004) S15
29. Khan R.N., Hamoud H., Warren A., Wong L.F., and Arulkumaran S. Relaxant action of sildenafil citrate (Viagra) on human myometrium of pregnancy. Am J Obstet Gynecol 191 (2004) 315
30. Mehats C., Schmitz T., Breuiller-Fouche M., Leroy M.J., and Cabrol D. Should phosphodiesterase 5 selective inhibitors be used for uterine relaxation?. Am J Obstet Gynecol 195 (2006) 184
31. Wong W., and Scott J.D. AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 5 (2004) 959
32. Ayres A.W., Carr D.W., McConnell D.S., Lieberman R.W., and Smith G.D. Expression and intracellular localization of protein phosphatases 2A and 2B, protein kinase a, A-Kinase anchoring protein (AKAP79), and binding of the regulatory (RII) subunit of protein kinase a to AKAP79 in human myometrium. J Soc Gynecol Investig 10 (2003) 428
33. MacDougall M.W., Europe-Finner G.N., and Robson S.C. Human myometrial quiescence and activation during gestation and parturition involve dramatic changes in expression and activity of particulate type II (RII alpha) protein kinase A holoenzyme. J Clin Endocrinol Metab 88 (2003) 2194
34. Ku C.Y., Word R.A., and Sanborn B.M. Differential expression of protein kinase A, AKAP79, and PP2B in pregnant human myometrial membranes prior to and during labor. J Soc Gynecol Investig 12 (2005) 421
35. Willoughby D., Wong W., Schaack J., Scott J.D., and Cooper D.M. An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. Embo J 25 (2006) 2051
36. Huang J., Zhou H., Mahavadi S., Sriwai W., and Murthy K.S. Inhibition of G{alpha}q-Dependent PLC-{beta}1 Activity by PKG and PKA is Mediated by Phosphorylation of RGS4 and GRK2. Am J Physiol Cell Physiol (2006)
37. Moore F., and López Bernal A. Myosin light chain kinase and the onset of labour in humans. Exp Physiol 86 (2001) 313
38. Choudhury N., Khromov A.S., Somlyo A.P., and Somlyo A.V. Telokin mediates Ca2+-desensitization through activation of myosin phosphatase in phasic and tonic smooth muscle. J Muscle Res Cell Motil 25 (2004) 657
39. Word R.A., Tang D.C., and Kamm K.E. Activation properties of myosin light chain kinase during contraction/relaxation cycles of tonic and phasic smooth muscles. J Biol Chem 269 (1994) 21596
40. Perez G., and Toro L. Differential modulation of large-conductance KCa channels by PKA in pregnant and nonpregnant myometrium. Am J Physiol 266 (1994) C1459
41. Meera P., Anwer K., Monga M., Oberti C., Stefani E., Toro L., et al. Relaxin stimulates myometrial calcium-activated potassium channel activity via protein kinase A. Am J Physiol 269 (1995) C312
42. Crowther C.A., Hiller J.E., and Doyle L.W. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev (2002) CD001060
43. Grimes D.A., and Nanda K. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol 108 (2006) 986
44. Csapo A.I., and Pulkkinen M. Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence. Obstet Gynecol Surv 33 (1978) 69
45. Dodd J.M., Flenady V., Cincotta R., and Crowther C.A. Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev (2006) CD004947
46. Mackenzie R., Walker M., Armson A., and Hannah M.E. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 194 (2006) 1234
47. Anotayanonth S., Subhedar N.V., Garner P., Neilson J.P., and Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev (2004) CD004352
48. Dodd J.M., Crowther C.A., Dare M.R., and Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database Syst Rev (2006) CD003927
49. Rouget C., Bardou M., Breuiller-Fouche M., Loustalot C., Qi H., Naline E., et al. Beta3-adrenoceptor is the predominant beta-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancy. J Clin Endocrinol Metab 90 (2005) 1644
50. Doheny H.C., Lynch C.M., Smith T.J., and Morrison J.J. Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes. J Clin Endocrinol Metab 90 (2005) 5786
51. Ulmsten U., Andersson K.E., and Wingerup L. Treatment of premature labor with the calcium antagonist nifedipine. Arch Gynecol 229 (1980) 1
52. Read M.D., and Wellby D.E. The use of a calcium antagonist (nifedipine) to suppress preterm labour. Br J Obstet Gynaecol 93 (1986) 933
53. Ferguson II J.E., Dyson D.C., Holbrook Jr. R.H., Schutz T., and Stevenson D.K. Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis. Am J Obstet Gynecol 161 (1989) 788
54. Melin P. Oxytocin antagonists in preterm labour and delivery. Baillieres Clin Obstet Gynaecol 7 (1993) 577
55. Akerlund M., Stromberg P., Hauksson A., Andersen L.F., Lyndrup J., Trojnar J., et al. Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol 94 (1987) 1040
56. Phaneuf S., Asboth G., MacKenzie I.Z., Melin P., and López Bernal A. Effect of oxytocin antagonists on the activation of human myometrium in vitro: atosiban prevents oxytocin-induced desensitization. Am J Obstet Gynecol 171 (1994) 1627
57. Worldwide-Atosiban-Study-Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. Bjog 108 (2001) 133
58. Houdeau E., Levy A., and Mhaouty-Kodja S. Up-regulation of rat myometrial phospholipases C{beta}1 and C{beta}3 correlates with increased term sensitivity to carbachol and oxytocin. J Endocrinol 187 (2005) 197
59. Quaas L., and Zahradnik H.P. The effects of alpha- and beta-adrenergic stimulation on contractility and prostaglandin (prostaglandins E2 and F2 alpha and 6-keto-prostaglandin F1 alpha) production of pregnant human myometrial strips. Am J Obstet Gynecol 152 (1985) 852
60. Breuiller M., Rouot B., Litime M.H., Leroy M.J., and Ferre F. Functional coupling of the alpha 2-adrenergic receptor-adenylate cyclase complex in the pregnant human myometrium. J Clin Endocrinol Metab 70 (1990) 1299
61. Berg G., Andersson R.G., and Ryden G. Beta-adrenergic receptors in human myometrium during pregnancy: changes in the number of receptors after beta-mimetic treatment. Am J Obstet Gynecol 151 (1985) 392
62. Bardou M., Loustalot C., Cortijo J., Simon B., Naline E., Dumas M., et al. Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium. Br J Pharmacol 130 (2000) 1960
63. Martinez-Mir M.I., Estan L., Morales-Olivas F.J., and Rubio E. Effect of histamine and histamine analogues on human isolated myometrial strips. Br J Pharmacol 107 (1992) 528
64. Kitazawa T., Hatakeyama H., Cao J., and Taneike T. Pregnancy-associated changes in responsiveness of the porcine myometrium to bioactive substances. Eur J Pharmacol 469 (2003) 135
65. Senior J., Sangha R., Baxter G.S., Marshall K., and Clayton J.K. In vitro characterization of prostanoid FP-, DP-IP- and TP-receptors on the non-pregnant human myometrium. Br J Pharmacol 107 (1992) 215
66. Senior J., Marshall K., Sangha R., and Clayton J.K. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br J Pharmacol 108 (1993) 501
67. Casey M.L., Smith J., Alsabrook G., and MacDonald P.C. Activation of adenylyl cyclase in human myometrial smooth muscle cells by neuropeptides. J Clin Endocrinol Metab 82 (1997) 3087
68. Bing C., Johnson I.R., and Broughton Pipkin F. Angiotensin receptors in myometrium and myometrial vessels from uteri of women during the follicular and luteal phases of the menstrual cycle and in late pregnancy. Clin Sci (Lond) 90 (1996) 499
69. Dong Y.L., Fang L., Kondapaka S., Gangula P.R., Wimalawansa S.J., and Yallampalli C. Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy. J Clin Invest 104 (1999) 559
70. Doheny H.C., Houlihan D.D., Ravikumar N., Smith T.J., and Morrison J.J. Human chorionic gonadotrophin relaxation of human pregnant myometrium and activation of the BKCa channel. J Clin Endocrinol Metab 88 (2003) 4310
71. Karteris E., Hillhouse E.W., and Grammatopoulos D. Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility. Endocrinology 145 (2004) 890
72. Word R.A., Kamm K.E., and Casey M.L. Contractile effects of prostaglandins, oxytocin, and endothelin-1 in human myometrium in vitro: refractoriness of myometrial tissue of pregnant women to prostaglandins E2 and F2 alpha. J Clin Endocrinol Metab 75 (1992) 1027
73. Martensson L.G., Andersson R.G., and Berg G. Melatonin together with noradrenaline augments contractions of human myometrium. Eur J Pharmacol 316 (1996) 273
74. Fuchs A.R., Fuchs F., Husslein P., and Soloff M.S. Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 150 (1984) 734
75. Kimura T., Takemura M., Nomura S., Nobunaga T., Kubota Y., Inoue T., et al. Expression of oxytocin receptor in human pregnant myometrium. Endocrinology 137 (1996) 780
76. Pennefather J.N., Patak E., Ziccone S., Lilley A., Pinto F.M., Page N.M., et al. Regulation of the stimulant actions of neurokinin a and human hemokinin-1 on the human uterus: a comparison with histamine. Biol Reprod 75 (2006) 334
77. Karteris E., Zervou S., Pang Y., Dong J., Hillhouse E.W., Randeva H.S., et al. Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol 20 (2006) 1519